ATE246359T1 - Nachweis von antikörpern gegen fiv unter benutzung von env/gag polypeptiden - Google Patents

Nachweis von antikörpern gegen fiv unter benutzung von env/gag polypeptiden

Info

Publication number
ATE246359T1
ATE246359T1 AT99303760T AT99303760T ATE246359T1 AT E246359 T1 ATE246359 T1 AT E246359T1 AT 99303760 T AT99303760 T AT 99303760T AT 99303760 T AT99303760 T AT 99303760T AT E246359 T1 ATE246359 T1 AT E246359T1
Authority
AT
Austria
Prior art keywords
fiv
env
antibodies
detection
gag polypeptides
Prior art date
Application number
AT99303760T
Other languages
English (en)
Inventor
Randall G Groat
Brion Mermer
Thomas P O'connor
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Application granted granted Critical
Publication of ATE246359T1 publication Critical patent/ATE246359T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/826Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99303760T 1998-05-15 1999-05-14 Nachweis von antikörpern gegen fiv unter benutzung von env/gag polypeptiden ATE246359T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8561598P 1998-05-15 1998-05-15
US09/089,878 US6458528B1 (en) 1998-05-15 1998-06-03 Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers

Publications (1)

Publication Number Publication Date
ATE246359T1 true ATE246359T1 (de) 2003-08-15

Family

ID=26772914

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99303760T ATE246359T1 (de) 1998-05-15 1999-05-14 Nachweis von antikörpern gegen fiv unter benutzung von env/gag polypeptiden

Country Status (8)

Country Link
US (1) US6458528B1 (de)
EP (1) EP0962774B1 (de)
JP (1) JP3374101B2 (de)
AT (1) ATE246359T1 (de)
AU (1) AU754309B2 (de)
CA (1) CA2271449C (de)
DE (1) DE69909897T2 (de)
ES (1) ES2200472T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219725A (en) * 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
AU2005267607B8 (en) * 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
ATE435425T1 (de) * 2003-09-11 2009-07-15 Idexx Lab Inc Verfahren zum nachweis des felinen immunschwächevirus
WO2005062053A2 (en) * 2003-12-18 2005-07-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2005080939A2 (en) * 2004-02-19 2005-09-01 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4866848B2 (ja) * 2004-06-30 2012-02-01 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルス(fiv)のenvタンパク質のv3領域に由来するペプチドの使用を含むfivを検出するための方法および装置
AU2005267605B2 (en) * 2004-06-30 2009-03-26 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
KR101069391B1 (ko) * 2008-08-25 2011-09-30 베트올 (주) 고양이 레트로바이러스 탐지용 항체, 및 이를 포함하는 면역탐지키트
WO2011123781A1 (en) * 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016143A (en) * 1971-12-07 1977-04-05 Bayer Aktiengesellschaft Polyurethanes based on aromatic polyamines
US4514505A (en) 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
US4743678A (en) 1983-04-27 1988-05-10 President And Fellows Of Harvard College Method and products for detection of human T cell leukemia virus
US4939096A (en) 1986-09-10 1990-07-03 Idexx, Corp. Method and apparatus for assaying whole blood
US4965187A (en) 1986-09-10 1990-10-23 Idexx Corporation Method and apparatus for assaying whole blood
US6107077A (en) 1987-08-26 2000-08-22 Yamamoto; Janet K. Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
CA1341439C (en) 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
CA1339723C (en) 1988-01-19 1998-03-17 Philip Mcmahon Immunoassay with multiple test spots
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
US5177014A (en) 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
JP3058685B2 (ja) * 1989-05-08 2000-07-04 アイデックス ラボラトリーズ インコーポレーテッド ネコt細胞リンパトロピック レンチウィルスのポリペプチド
ATE160358T1 (de) 1991-06-14 1997-12-15 St Vincents Inst Med Res Detektion des immunschwäche-virus aus felis
US5726010A (en) * 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US5413927A (en) 1991-09-03 1995-05-09 North Carolina State University Feline immunodeficiency virus isolate NCSU1Lb
AU2234995A (en) * 1994-04-29 1995-11-29 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
DE69636440D1 (de) * 1995-08-25 2006-09-21 Univ Florida IL-2 unabhängige T-Zellen der Katze
US5700655A (en) 1995-11-14 1997-12-23 Idexx Laboratories, Inc. Method for quantification of biological material in a sample
GB9719357D0 (en) 1997-09-11 1997-11-12 Ortho Clinical Diagnostics Immunoassay Utilizing Two Incubations With Labelled Antigen

Also Published As

Publication number Publication date
DE69909897T2 (de) 2004-05-27
AU2806799A (en) 1999-11-25
CA2271449C (en) 2010-07-13
JP2000002707A (ja) 2000-01-07
US6458528B1 (en) 2002-10-01
JP3374101B2 (ja) 2003-02-04
AU754309B2 (en) 2002-11-14
CA2271449A1 (en) 1999-11-15
EP0962774A1 (de) 1999-12-08
ES2200472T3 (es) 2004-03-01
DE69909897D1 (de) 2003-09-04
EP0962774B1 (de) 2003-07-30

Similar Documents

Publication Publication Date Title
ATE246359T1 (de) Nachweis von antikörpern gegen fiv unter benutzung von env/gag polypeptiden
DE68928834D1 (de) Monoklonale antikörper gegen katzen-t-lymphotropes lentivirus
AU637097B2 (en) Process for preparing an improved western blot immunoassay
EP0345462A3 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde
EP0231914A3 (en) Htlv-iii envelope peptides
DK0891982T3 (da) HIV-peptider
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
DE3784484D1 (de) Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz.
EP1475442A3 (de) Lymphotropische Polypeptide von dem Lentivirus von den T-zellen der Katze
Ma et al. A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
DK637988D0 (da) Rekombinante polypeptider
DE69523055D1 (de) T-zellen stimulierendes protein von pestivirus
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
MX9206018A (es) Vacunas contra el virus de la leucemia felina
SE9101863D0 (sv) Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
Chen et al. Identification of a recombinant HTLV-II envelope protein for serological detection of HTLV-II carriers
Shimizu et al. Absence of anti-human herpesvirus 8 antibody in 32 Japanese hemophiliacs with advanced HIV infection.
FR2874017B1 (fr) Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih
FI890443A7 (fi) HIV-polypeptidi, sen valmistus ja käyttö HIV-vasta-aineiden toteamisek si
DK697188D0 (da) Fremgangsmaade til detektering af antistof mod hiv (human immunodeficiency virus)
KR900005991A (ko) 옥트레오티드(Octreotide)를 함유한 약학적 조성물
ATE86120T1 (de) Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz.
MX9707020A (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties